{"id":"https://openalex.org/W43171073","doi":null,"title":"[Risperidone in the treatment of psychotic patients with opiate abuse and dependence].","display_name":"[Risperidone in the treatment of psychotic patients with opiate abuse and dependence].","publication_year":2001,"publication_date":"2001-11-01","ids":{"openalex":"https://openalex.org/W43171073","mag":"43171073","pmid":"https://pubmed.ncbi.nlm.nih.gov/11730575"},"language":"es","primary_location":{"id":"pmh:oai:actaspsiquiatria.es:article/436","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/436","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/436/642","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://actaspsiquiatria.es/index.php/actas/article/download/436/642","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016635569","display_name":"Miguel Casas","orcid":"https://orcid.org/0000-0003-3496-8522","observed_orcids":["https://orcid.org/0000-0003-3496-8522"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M Casas","raw_affiliation_strings":["Universidad Aut\u00f3noma, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad Aut\u00f3noma, Barcelona, Spain","institution_ids":["https://openalex.org/I123044942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107841626","display_name":"M. Guti\u00e9rrez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Guti\u00e9rrez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036825383","display_name":"Juan Gibert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Gibert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083202579","display_name":"Julio Bobes","orcid":"https://orcid.org/0000-0003-2187-4033","observed_orcids":["https://orcid.org/0000-0003-2187-4033"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Bobes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063092297","display_name":"Carlos Roncero","orcid":"https://orcid.org/0000-0003-1421-7385","observed_orcids":["https://orcid.org/0000-0003-1421-7385","https://orcid.org/0009-0004-1829-1456"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Roncero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5013666785","display_name":"I Octavio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I Octavio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1853,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.52028518,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"29","issue":"6","first_page":"380","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0478999987244606,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.02419999986886978,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/psychosis","display_name":"psychosis","score":0.7419999837875366},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9309999942779541},{"id":"https://openalex.org/keywords/opiate-abuse","display_name":"opiate abuse","score":0.9340000152587891},{"id":"https://openalex.org/keywords/dual-pathology","display_name":"dual pathology","score":0.7599999904632568},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7860000133514404},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6200000047683716},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.625},{"id":"https://openalex.org/keywords/neurological-adverse-events","display_name":"neurological adverse events","score":0.8059999942779541},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9549999833106995},{"id":"https://openalex.org/keywords/disability","display_name":"disability","score":0.33799999952316284}],"concepts":[{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8909251093864441},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7554386854171753},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6764833927154541},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.5935558676719666},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.5578683614730835},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5549102425575256},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5303010940551758},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.49962568283081055},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.36862653493881226},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.2126157581806183},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.14996352791786194},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010054","descriptor_name":"Brief Psychiatric Rating Scale","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmh:oai:actaspsiquiatria.es:article/436","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/436","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/436/642","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:11730575","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11730575","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Actas espanolas de psiquiatria","raw_type":"English Abstract"},{"id":"mag:43171073","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11730575","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:actaspsiquiatria.es:article/436","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/436","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/436/642","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W43171073.pdf","grobid_xml":"https://content.openalex.org/works/W43171073.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7217604440","https://openalex.org/W1921760074","https://openalex.org/W2079646955","https://openalex.org/W7218175673","https://openalex.org/W2531486752","https://openalex.org/W2237595605","https://openalex.org/W7216911653","https://openalex.org/W82072493","https://openalex.org/W2029748394","https://openalex.org/W2399713249"],"abstract_inverted_index":{"INTRODUCTION:":[0],"180":[1],"psychotic":[2,189],"patients":[3,77,106,163],"with":[4,78],"opiate":[5,104],"dependence":[6],"and":[7,24,49,56,63,90,182,191],"abuse":[8,105],"(ICD-10)":[9],"were":[10,20,51,178],"included":[11,76],"in":[12,82,122,203],"an":[13,200],"open":[14],"label":[15],"study.":[16],"The":[17,34],"study":[18,145],"objectives":[19],"to":[21,53,110,157,220],"evaluate":[22],"safety":[23],"efficacy":[25,55],"of":[26,74,87,97,161,193,206,209,229],"risperidone":[27,217],"for":[28,59,66,127,136,231],"a":[29,79,117,226],"six":[30],"month":[31,96,113],"follow-up":[32],"period.":[33],"total":[35,85,124],"mean":[36,84,199],"dose":[37],"was":[38,116,140],"4.4":[39],"(SD:":[40],"2.4":[41],"mg/daily;":[42],"range:":[43],"0.5-12":[44],"mg/daily).":[45],"METHODS:":[46],"BPRS,":[47,88],"CGI":[48,89],"DDS-SV":[50,91],"used":[52],"assess":[54],"UKU":[57,125],"subscale":[58,126],"neurological":[60,128],"side":[61,129],"effects":[62,130,180],"spontaneous":[64,176],"reports":[65,177],"safety.":[67],"RESULTS:":[68],"Risperidone":[69,100,139,186],"treatment":[70,98,155,205,230],"improved":[71,187],"symptoms,":[72],"disability":[73],"the":[75,83,94,123,144,162,170,204],"significant":[80,118],"reduction":[81,119],"scores":[86,131],"observed":[92],"from":[93,107,132],"first":[95],"onwards.":[99],"also":[101],"reduced":[102],"illegal":[103],"39%":[108],"basedate":[109],"18%":[111],"at":[112],"6.":[114],"There":[115],"(p<":[120],"0.0001)":[121],"visit":[133],"1":[134],"onwards":[135],"studied":[137],"sample.":[138],"well":[141],"tolerated":[142],"by":[143],"patients.":[146,195],"From":[147],"165":[148],"elegible":[149],"patients,":[150],"just":[151],"10":[152],"(6.1%)":[153],"discontinued":[154],"due":[156],"adverse":[158,168,173],"reactions,":[159],"94%":[160],"did":[164],"not":[165],"suffer":[166],"any":[167],"event;":[169],"most":[171],"frequent":[172],"events":[174],"according":[175],"extrapyramidal":[179],"(3%)":[181],"anxiety":[183],"(1.8%).":[184],"DISCUSSION:":[185],"disability,":[188],"symptoms":[190],"tolerability":[192],"these":[194,207],"Those":[196],"results":[197],"could":[198],"outstanding":[201],"breakthrough":[202],"type":[208],"disorders":[210],"and,":[211],"if":[212],"it":[213],"is":[214],"confirmed":[215],"that":[216],"can":[218],"lead":[219],"abstinence,":[221],"we":[222],"would":[223],"be":[224],"before":[225],"new":[227],"line":[228],"dual":[232],"pathology.":[233]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}